Accelerate Diagnostics (AXDX) Misses Q2 EPS by 5c

Accelerate Diagnostics (NASDAQ: AXDX) reported Q2 EPS of ($0.37), $0.05 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• L3Harris CEO steps down amid conduct review, shares drop